 | • レポートコード：MRC2108A020 • 出版社/出版日：Mordor Intelligence / 2021年7月26日 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、動物用ホルモン療法の世界市場規模が、2021年から2026年の間に年平均5.52％成長すると予測しています。本調査レポートは、世界の動物用ホルモン療法市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（成長促進剤、能力向上剤、その他）分析、動物別（伴侶動物、家畜）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・動物用ホルモン療法の世界市場規模：用途別（成長促進剤、能力向上剤、その他） ・動物用ホルモン療法の世界市場規模：動物別（伴侶動物、家畜） ・動物用ホルモン療法の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Merck & Co. Inc、Zoetis, Inc、Elanco (Bayer Animal Health)、Boehringer Ingelheim、Bimeda Animal Health、Vetoquinol SA、Virbac Group、CEVA Sante Animale、HIPRA Animal Health、Syntex SA、Huvepharma、Jurox Pty Ltd.） ・市場機会/将来の見通し |
The Animal Hormone Therapy market studied is expected to grow with an estimated CAGR of 5.52%, over the forecast period.
With the outbreak of COVID-19, the animal hormone therapy industry has faced both patterns. Initially when the pandemic strike, with raise in a sudden demand for meat, eggs, milk, and other animal food products, the industry faced a sudden spike in demand for growth promoters and performance enhancers. Since animal food processing is not such a process where human involvement and proximity are avoided with animals and humans. The units have to shut amid the threat of spreading the COVID-19. Thus, the market faced a demand reduction. However, the animal hormone used for therapeutic purposes for animals remains continuously in demand and has supported the industry. Thus, COVID-19 is expected to show a considerable positive impact on the animal hormone therapy market.
The study market growth is predominantly characterized by factors such as the growing burden of hormonal deficiency diseases in animals, rising demand for meat, and increasing animal husbandry. The growing burden of diseases in animals drives the market by focusing on hormones used in the treatment of hormonal deficiency diseases, neoplasia treatment, or replacement therapy. According to the Pathogenesis of Endocrine Disease in Animals Article of April 2019, hyperthyroidism, type I diabetes mellites, primary hyperparathyroidism, and primary hyperadrenocorticism are the most common diseases in small animals that involves endocrine hypofunction. Animal hormones are used for fattening and production boosting purposes in the animal food industry. Further, in June 2021, the United States Department of Agriculture reported a decline in beef production over a year but a strong demand for broilers, turkey, and pork. Further, the number of animal husbandry is increasing all over the globe which largely concerns with animal hormone use for better health of animals. According to the Report of National Agricultural Statistics Services, United States of America, April 2021, Broiler Production in the United States is increasing from the last 5 decades; 1970-2020. Thus, concerning the above facts, the animal hormone market is expected to witness large growth over the Forecast Period.
Although animal hormone therapy has wide applications, the risk associated with the use of animal hormone and the stringent regulatory norms associated with its use may hamper the growth of the animal hormone therapy market.
Key Market Trends
Livestock Animal Segment is Expected to Boosts Market Over the Forecast Period
Hormones can be used as a supplement or to replace any particular deficient hormone in animals. The steroidal hormones such as androgens, estradiol, progesterone, and testosterone are anabolic hormones used for promoting growth, production, and breeding in animals. The steroidal hormones are either implanted in-ear or injected intramuscularly into the animals.
Livestock animals include cattle, swine, poultry, aquaculture species, etc. The response of hormones varies largely among animals. When the same concentration use of estradiol is used in pigs and cattle to increase meat products, the very less increase in lean meat is seen as compared to cattle. Further, in the United States, any feed ingredients and medicines that are administered to animals are regulated by United States Food and Drug Administration (USFDA). Moreover, According to National Agricultural Statistics Service (NASS) report, the total number of cattle heads in the United States is found 94.8 million in Jan 2019 which is reduced to 93.6 million in Jan 2021. However, in order to meet the rising demand for meat consumption among population, the demand for hormonal therapy is expected to grow in the future.
North America Holds Significant Share in Market and Expected to Grow in the Forecast Period
North America, along with Canada, the United States, and Mexico is one of the very well infrastructure animal health facilities. Along with focusing on continuous research on animal and technological advanced processes for animal products processing, North America is expected to dominate the market over the forecast period.
Moreover, According to the Feb 2020 Report of the FCC Economics, Domestic demand for red meat in Canada has remained robust in 2020. There is a significant rise in the price of beef by 3.5%, 0.7% in pork, and 3% in chicken compared to 2019. Implying that a rise in demand for meat in the market accounts for more business. Further, in June 2021, Poultry World Article reported that net egg production in Canada has raised by 2.1% in the year 2020, accounting for a rise in the value of 3.9% compared to the previous year 2019. The increasing demand for nutritious and healthy animal-derived products directly boosts the demand for performance enhancers and health and growth-promoting feeds and supplies. Further, in June 2021, the United States Department of Agriculture (USDA) announced to invest in mid and small-sized poultry processors and producers of about USD 55.2 million to build capacity and increasing economic opportunity for them across the country. Thus, the government authorities are taking steps to encourage the participation of different level players across the globe to make North American Market, a preferable choice by industry players.
Competitive Landscape
The Animal Hormone Therapy market is highly competitive with several players across the globe. In terms of market share, major players currently dominate the market. With the increasing burden of diseases and technological advancement in animal healthcare, many new players are expected to be part of the animal hormone therapy market over the forecast period. Some of the major players of the market are Merck & Co. Inc, Boehringer Ingelheim, Elanco, Inc, Virbac Group, and Vetoquinol SA.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Hormonal Deficiency Diseases inAnimals
4.2.2 Rising Demand of Meat
4.2.3 Increase in Animal Husbandary
4.3 Market Restraints
4.3.1 Side Effects Associated with Use of Animal Hormones
4.3.2 Stringent Government Regulations Associated with Animal Hormones
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Application
5.1.1 Growth Promotors
5.1.2 Performance Enhancers
5.1.3 Others
5.2 By Animals
5.2.1 Companion Animals
5.2.2 Livestock
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Merck & Co. Inc
6.1.2 Zoetis, Inc
6.1.3 Elanco (Bayer Animal Health)
6.1.4 Boehringer Ingelheim
6.1.5 Bimeda Animal Health
6.1.6 Vetoquinol SA
6.1.7 Virbac Group
6.1.8 CEVA Sante Animale
6.1.9 HIPRA Animal Health
6.1.10 Syntex SA
6.1.11 Huvepharma
6.1.12 Jurox Pty Ltd.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS